Multicenter Randomized Controlled Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion in the Treatment of Preoperative Anaemia in Colorectal Cancer Patients
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2018
Price : $35 *
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Ferrous fumarate
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms FIT
- 27 Aug 2018 Planned End Date changed from 1 Dec 2016 to 1 Dec 2019.
- 27 Aug 2018 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2019.
- 17 Jun 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.